Emerging Technologies for the Treatment of Structural Heart Disease
Overview
In the past decade, novel minimally invasive and percutaneous therapies have been developed to treat patients with structural heart disease. In this program, cardiovascular specialists will utilize focused didactics, relevant case material, and targeted discussion to present the latest technologies to treat patients with complex structural heart disease. We invite you to join this interactive and multifaceted educational forum.
Educational Objectives
At the completion of the course, participants should be able to
- Understand and apply novel minimally invasive techniques to treat their patients with valvular disease
- Evaluate and choose the best option to treat adult patients with congenital heart disease
- Implement, based on latest research and technology, the best techniques to treat the adult patient with a history of strokes
Target Audience
The intended audience for the Advances in Cardiac Science and Therapeutics Series is Cardiologists, Internists, Cardiac-Thoracic and Vascular Surgeons, Electrophysiologists, and Interventional Cardiologists, as well as other healthcare professionals who treat and manage heart disease.
Accreditation and Credit Designation
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other health professionals will receive a Certificate of Attendance. For information on applicability and acceptance, please consult your professional licensing board.